Sectors

RYTM
Rhythm Pharmaceuticals, Inc.
116.02
1 x 114.32
1 x 118.32
bid
ask
-
1.58
1.34%
1 @ 04:00 PM
114.70 -1.32 (1.14%)
Ytd8.39%
1y18.56%
114.00
day range
119.75
74.50
52 week range
122.20
Open118.19Prev Close117.60Low114.00High119.75Mkt Cap7.96B
Vol751.99KAvg Vol782.13KEPS-3.11P/E-37.31Forward P/E-189.75
Beta1.97Short Ratio14.32Inst. Own115.25%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0450-d Avg103.45200-d Avg99.121yr Est141.53

RYTM News

Why Is Rhythm Pharmaceuticals Stock Trading Higher On Wednesday?
benzinga.com
Why Is Rhythm Pharmaceuticals Stock Trading Higher On Wednesday?

Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) shares are trading higher on Wednesday.

Rhythm Pharmaceuticals Q2 Earnings Call Highlights
defenseworld.net
Rhythm Pharmaceuticals Q2 Earnings Call Highlights

Rhythm Pharmaceuticals (NASDAQ: RYTM) reported second-quarter 2026 global net product sales of $71.3

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
globenewswire.com
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comm

Rhythm Pharmaceuticals, Inc. (RYTM) Q2 2026 Earnings Call Transcript
seekingalpha.com
Rhythm Pharmaceuticals, Inc. (RYTM) Q2 2026 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (RYTM) Q2 2026 Earnings Call Transcript

Rhythm Pharmaceuticals Q2 Earnings Call Highlights
marketbeat.com
Rhythm Pharmaceuticals Q2 Earnings Call Highlights

Rhythm Pharmaceuticals NASDAQ: RYTM reported second-quarter 2026 global net product sales of $71.3 m

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates
zacks.com
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates

Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.73 per share versus the Zac

Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
reuters.com
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition

Rhythm Pharmaceuticals said on Tuesday its experimental weekly injectable drug helped reduce body we

Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
globenewswire.com
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

-- U.S. launch of IMCIVREE ® (setmelanotide) for acquired hypothalamic obesity (HO) starts strong wi

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity
globenewswire.com
Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated

-- -11.6% mean reduction in BMI from baseline at Week 16 (n=7) -- -- BMI reductions consistent with

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
zacks.com
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Re

Rhythm Pharmaceuticals (RYTM) possesses the right combination of the two key ingredients for a likel

Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm
prnewswire.com
Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm

NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves

Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
globenewswire.com
Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

BOSTON, July 21, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comm

Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm
globenewswire.com
Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i

Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity
globenewswire.com
Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEN

BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comm

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Positive Interim Results from Phase 2 Setmelanotide Trial in Prader-Willi Syndrome Transcript
seekingalpha.com
Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Positive Interim Results from Phase 2 Setmelanotide Tr

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Positive Interim Results from Phase 2 Setmelanotide Tr

Rhythm Pharmaceuticals posts long-term setmelanotide data for obesity
proactiveinvestors.com
Rhythm Pharmaceuticals posts long-term setmelanotide data for obesity

Rhythm Pharmaceuticals, Inc. (NASDAQ: RGPX) reported that setmelanotide therapy produced robust, sus

Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026
globenewswire.com
Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypo

BOSTON, June 15, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comm

Why Is Rhythm Pharma Stock Jumping Today?
benzinga.com
Why Is Rhythm Pharma Stock Jumping Today?

Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock is trading higher on Monday after the company report

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
globenewswire.com
Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide

-- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
Earnings Scheduled For August 5, 2025

benzinga.com
Earnings Scheduled For May 7, 2025

benzinga.com
Earnings Scheduled For February 26, 2025

benzinga.com
Earnings Scheduled For February 22, 2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings

benzinga.com
Earnings Scheduled For November 7, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

benzinga.com
Earnings Scheduled For August 1, 2023

Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for it

benzinga.com
Earnings Scheduled For March 1, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss a

benzinga.com
Earnings Scheduled For November 8, 2022

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings a

benzinga.com
Stocks That Hit 52-Week Lows On Monday

    During Monday's session, 291 companies made new 52-week lows. Also check out this: Insid

benzinga.com
Stocks That Hit 52-Week Lows On Friday

    On Friday morning, 155 companies achieved new lows for the year.

benzinga.com
Earnings Scheduled For August 3, 2021

  Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday

benzinga.com
60 Biggest Movers From Yesterday

60 Biggest Movers From Yesterday